Skip to main content
. Author manuscript; available in PMC: 2024 Apr 25.
Published in final edited form as: Sex Transm Infect. 2015 Apr 22;91(7):485–488. doi: 10.1136/sextrans-2014-051867

Table 1.

Baseline characteristics by trial arm

Enrolment characteristics Treatment Placebo p Value

N Per cent N Per cent
Total 148 100.0 153 100.0

Age (years) 0.980
 20–29 37 25 36 24
 30–39 65 44 66 43
 40–49 31 21 35 23
 50+ 15 10 16 10
CD4+ T cell count 0.564
 300–349 69 47 66 43
 350–399 79 53 87 57
HIV Viral load categories 0.973
 <10000 53 36 54 35
 10000–49999 43 29 43 28
 50000–99999 13 9 16 10
 100000+ 39 26 40 26
Log10 HIV viral load
 Median (IQR) 4.33 (3.77–5.03) 4.39 (3.66–5.04) 0.880
sCD14 0.300
 <Median 79 53 72 47
 Median+ 69 47 81 53
Log10 sCD14
 Median (IQR) 3.31 (3.20–3.45) 3.34 (3.20–3.43) 0.816
CRP 0.084
 <Median 82 55 69 45
 Median+ 66 45 84 55
Log10 CRP
 Median (IQR) 0.99 (0.40–3.30) 1.32 (0.46–3.86) 0.329

CRP, C-reactive protein.